Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia

被引：0
|
作者：
Al-Motassem Yousef
Rand Farhad
Daniah Alshamaseen
Abrar Alsheikh
Mohammed Zawiah
Taha Kadi
机构：
[1] The University of Jordan,Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
ALL; MTX; Toxicity; Genetic polymorphisms; Folate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：755 / 762
页数：7
相关论文
共 50 条
  • [31] Folate Pathway Gene Polymorphisms, Maternal Folic Acid Use, and Risk of Childhood Acute Lymphoblastic Leukemia
    Milne, Elizabeth
    Greenop, Kathryn R.
    Scott, Rodney J.
    Haber, Michelle
    Norris, Murray D.
    Attia, John
    Jamieson, Sarra E.
    Miller, Margaret
    Bower, Carol
    Bailey, Helen D.
    Dawson, Somer
    McCowage, Geoffrey B.
    de Klerk, Nicholas H.
    van Bockxmeer, Frank M.
    Armstrong, Bruce K.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (01) : 48 - 56
  • [32] Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia
    Taub, JW
    Matherly, LH
    Ravindranath, Y
    Kaspers, GJL
    Rots, MG
    van Zantwijk, CH
    LEUKEMIA, 2002, 16 (04) : 764 - 765
  • [33] Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma
    Shimasaki, N
    Mori, T
    Samejinia, R
    Sato, R
    Shimada, IK
    Yahagi, N
    Torii, C
    Yoshihara, H
    Tanigawara, Y
    Takahashi, T
    Kosaki, K
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2006, 28 (02) : 64 - 68
  • [34] Association of genetic polymorphisms in the folate pathway with efficacy and toxicity of methotrexate in pediatric osteosarcoma
    Park, Jeong A.
    Kang, Hyoung Jin
    Im, Ho Joon
    Shin, Hee Young
    Ahn, Hyo Seop
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Polymorphisms in the Thymidylate Synthetase (TYMS) Gene in Relation to Methotrexate-Induced Oral Mucositis in Children with Acute Lymphoblastic Leukemia
    Oosterom, N.
    Berrevoets, M.
    Den Hoed, M.
    Pluijm, S.
    Pieters, R.
    De Jonge, R.
    Tissing, W.
    Van den Heuvel-Eibrink, M.
    Heil, S.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S18 - S18
  • [36] Update on MTHFR Pharmacogenetics and Methotrexate Toxicity in Childhood Acute Lymphoblastic Leukemia
    Lopez-Lopez, E.
    Martin-Guerrero, I.
    Ballesteros, J.
    Uriz, J.
    Pinan, M. A.
    Garcia-Miguel, P.
    Navajas, A.
    Garcia-Orad, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S286 - S286
  • [37] Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis
    Yang, Lin
    Hu, Xin
    Xu, Luhang
    TUMOR BIOLOGY, 2012, 33 (05) : 1445 - 1454
  • [38] Folate Metabolism and Risk of Childhood Acute Lymphoblastic Leukemia: A Genetic Pathway Analysis from the Childhood Cancer and Leukemia International Consortium
    Metayer, Catherine
    Spector, Logan G.
    Scheurer, Michael E.
    Jeon, Soyoung
    Scott, Rodney J.
    Takagi, Masatoshi
    Clavel, Jacqueline
    Manabe, Atsushi
    Ma, Xiaomei
    Hailu, Elleni M.
    Lupo, Philip J.
    Urayama, Kevin Y.
    Bonaventure, Audrey
    Kato, Motohiro
    Meirhaeghe, Aline
    Chiang, Charleston W. K.
    Morimoto, Libby M.
    Wiemels, Joseph L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09) : 1248 - 1252
  • [39] Identification of Risk Factors in High-Dose Methotrexate-Induced Acute Kidney Injury in Childhood Acute Lymphoblastic Leukemia
    Cheng, Dao-Hai
    Lu, Hua
    Liu, Tao-Tao
    Zou, Xiao-Qin
    Pang, Hui-Mei
    CHEMOTHERAPY, 2018, 63 (02) : 100 - 106
  • [40] Methotrexate-induced Acute Myelopathy in a Teenager With High-risk Acute Lymphoblastic Leukemia
    Geurten, Claire
    Forget, Patricia
    Leroy, Patricia
    Barrea, Christophe
    Hoyoux, Claire
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (04) : E262 - E264
12345